NEW YORK, March 06, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Callon Petroleum Company (CPE), Dynegy Inc. (DYN), Danaher Corporation (DHR), HollyFrontier Corporation (HFC), Aevi Genomic Medicine, Inc. (GNMX), and Apache Corporation (APA), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
CPE DOWNLOAD: http://Fundamental-Markets.com/register/?so=CPE
DYN DOWNLOAD: http://Fundamental-Markets.com/register/?so=DYN
DHR DOWNLOAD: http://Fundamental-Markets.com/register/?so=DHR
HFC DOWNLOAD: http://Fundamental-Markets.com/register/?so=HFC
GNMX DOWNLOAD: http://Fundamental-Markets.com/register/?so=GNMX
APA DOWNLOAD: http://Fundamental-Markets.com/register/?so=APA
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine Callon Petroleum Company (CPE), Dynegy Inc. (DYN), Danaher Corporation (DHR), HollyFrontier Corporation (HFC), Aevi Genomic Medicine, Inc. (GNMX), and Apache Corporation (APA) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed March 2nd, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
CALLON PETROLEUM COMPANY (CPE) REPORT OVERVIEW
Callon Petroleum's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Callon Petroleum reported revenue of $118.21MM vs $69.08MM (up 71.12%) and basic earnings per share $0.09 vs $0.20 (down 55.00%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Callon Petroleum reported revenue of $366.47MM vs $200.85MM (up 82.46%) and basic earnings per share $0.56 vs -$0.78. Callon Petroleum is expected to report earnings on May 1st, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.10. The estimated EPS forecast for the next fiscal year is $1.21 and is expected to report on February 26th, 2019.
To read the full Callon Petroleum Company (CPE) report, download it here: http://Fundamental-Markets.com/register/?so=CPE
-----------------------------------------
DYNEGY INC. (DYN) REPORT OVERVIEW
Dynegy's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Dynegy reported revenue of $994.00MM vs $1,107.00MM (down 10.21%) and basic earnings per share -$0.78 vs -$1.11. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Dynegy reported revenue of $4,842.00MM vs $4,318.00MM (up 12.14%) and basic earnings per share $0.37 vs -$9.78. Dynegy is expected to report earnings on May 3rd, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$0.03. The estimated EPS forecast for the next fiscal year is -$0.03 and is expected to report on February 20th, 2019.
To read the full Dynegy Inc. (DYN) report, download it here: http://Fundamental-Markets.com/register/?so=DYN
-----------------------------------------
DANAHER CORPORATION (DHR) REPORT OVERVIEW
Danaher's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Danaher reported revenue of $5,085.70MM vs $4,584.30MM (up 10.94%) and basic earnings per share $1.23 vs $1.07 (up 14.95%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Danaher reported revenue of $18,329.70MM vs $16,882.40MM (up 8.57%) and basic earnings per share $3.58 vs $3.69 (down 2.98%). Danaher is expected to report earnings on April 19th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.85. The estimated EPS forecast for the next fiscal year is $4.74 and is expected to report on January 29th, 2019.
To read the full Danaher Corporation (DHR) report, download it here: http://Fundamental-Markets.com/register/?so=DHR
-----------------------------------------
HOLLYFRONTIER CORPORATION (HFC) REPORT OVERVIEW
HollyFrontier's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, HollyFrontier reported revenue of $3,992.71MM vs $2,955.07MM (up 35.11%) and basic earnings per share $2.94 vs $0.31 (up 848.39%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, HollyFrontier reported revenue of $14,251.30MM vs $10,535.70MM (up 35.27%) and basic earnings per share $4.54 vs -$1.48. HollyFrontier is expected to report earnings on May 2nd, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$0.19. The estimated EPS forecast for the next fiscal year is $3.60 and is expected to report on February 20th, 2019.
To read the full HollyFrontier Corporation (HFC) report, download it here: http://Fundamental-Markets.com/register/?so=HFC
-----------------------------------------
AEVI GENOMIC MEDICINE, INC. (GNMX) REPORT OVERVIEW
Aevi Genomic Medicine's Recent Financial Performance
Aevi Genomic Medicine is expected to report earnings on March 8th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was -$0.22. The estimated EPS forecast for the next fiscal year is -$0.69 and is expected to report on March 8th, 2018.
To read the full Aevi Genomic Medicine, Inc. (GNMX) report, download it here: http://Fundamental-Markets.com/register/?so=GNMX
-----------------------------------------
APACHE CORPORATION (APA) REPORT OVERVIEW
Apache's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Apache reported revenue of $1,586.00MM vs $1,451.00MM (up 9.30%) and basic earnings per share $1.20 vs -$0.48. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Apache reported revenue of $6,423.00MM vs $5,354.00MM (up 19.97%) and basic earnings per share $3.42 vs -$3.71. Apache is expected to report earnings on May 3rd, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.08. The estimated EPS forecast for the next fiscal year is $1.41 and is expected to report on February 28th, 2019.
To read the full Apache Corporation (APA) report, download it here: http://Fundamental-Markets.com/register/?so=APA
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com
© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.